FDA Announces Some Acellular Dermal Matrices In Breast Reconstruction May Have Higher Chance for Complications

On March 31, 2021, the U.S. Food and Drug Administration (FDA) announced that certain acellular dermal matrix (ADM) products used in implant-based breast reconstruction may have a higher chance for complications or problems. There are several methods for reconstructing the breast following mastectomy (surgical removal of the breast). For patients who will have breast reconstruction […]

Dr. Kenneth Hughes is an expert in breast augmentation surgery and breast augmentation revision surgery. He also wrote the chapter on breast augmentation revision surgery with the use of acellular dermal matrices. Therefore, Dr. Hughes frequently advises of the latest developments of acellular dermal matrices in the breast augmentation and reconstruction realms. The ASPS recapped […]